Clinical Trials · NCT01638026

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
HaEmek Medical Center, Israel
Enrollment
93
Start date
Sep 2012
Locations
1 site, Israel
Primary endpoint
fertilization rate
View Gonadorelin compound reference